AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ESZOPICLONE
8 registrations across 4 African markets— 8 active
Markets with ESZOPICLONE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SLEEPGABA 3 Film Coated Tablets | 🇷🇼Rwanda | HETERO LABS LIMITED | active | Aug 2029 |
| ZOPIMAC 2 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MACLEODS PHARMACEUTICALS LIMITED | active | Dec 2027 |
| Zopimac 2 Oral tablet | 🇹🇿Tanzania | Macleods Pharmaceuticals Limited | active | — |
| ESZOPICLONE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
| ESZOPICLONE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
| ESZOPICLONE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
| Zopimac 3 Oral tablet | 🇹🇿Tanzania | Macleods Pharmaceuticals Limited | active | — |
| ESZOPICLONE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
ESZOPICLONE in Africa — Regulatory Overview
ESZOPICLONE is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Tanzania, Rwanda, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 8 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.